After a testy few days for a penny share our writer holds, he revisits the investment case and weighs management claims that ...

Anavex faces regulatory scrutiny with Alzheimer's drug submission. Despite trial setbacks, cognitive improvements shown. Read ...

Tune in to the fourth episode of our new In Practice: mini-series of podcasts hosted in partnership with Lloyds, which takes ...

The government seems uncertain about how to optimize the country's demographic potential to help Indonesia escape the ...

Looking for a semi-passive side hustle? Digital products are a great way to make money online. Find out how you can succeed ...

Upstream Bio's verekitug targets severe asthma, CRSwNP, and COPD, with promising early phase 2 data expected in 2025 and 2026 ...